PIWI Interacting RNA-823: Epigenetic Regulator of The Triple Negative Breast Cancer Cells Proliferation
Yıl: 2022 Cilt: 6 Sayı: 4 Sayfa Aralığı: 339 - 344 Metin Dili: İngilizce DOI: 10.14744/ejmo.2022.12505 İndeks Tarihi: 19-05-2023
PIWI Interacting RNA-823: Epigenetic Regulator of The Triple Negative Breast Cancer Cells Proliferation
Öz: Objectives: Triple negative breast cancer cells are estrogen, progesterone, and HER receptor negative, malign breast cancer cells. These cells have high telomerase activity, and this activity gives these cells high proliferation and evading apoptosis abilities. In this study, we aimed to determine the affect piR-823 on genetic parameters of proliferation and ERα status in MDA-MB-231 cells. Methods: After anti-piR-823 transfection, proliferation of cells was tested by XTT. Gene expressions were determined by RT-PCR. Protein expressions were determined by ELISA. Results: The proliferation decreased after inhibition (p<0.001). Gene and protein expressions of ERα were upregulated while hTERT was downregulated after inhibition (p<0.001). Furthermore, piR-823 inhibition cause to decrease PI3K/ AKT/mTOR gene expressions and miR-126 expression (p<0.001). Conclusion: Obtained data indicates that piR-823 inhibition lead MDA-MB-231 cells to increase ERα expression. De- creased expressions of hTERT and PI3K/AKT/mTOR pathway affect cell proliferation. Moreover, miR-126 decrease in- dicates that piRNAs and miRNAs can share the same target molecules and piRNA expression changes might have an impact on miRNA expressions. All obtained data is important on the perspective of piRNAs and their effect on cellular characteristics of triple negative breast cancer cells.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- 1. Sadoughi F, Mirhashemi SM, Asemi Z. Epigenetic roles of PIWI proteins and piRNAs in colorectal cancer. Cancer Cell Int 2021;21:328. [CrossRef ]
- 2. Cheng J, Deng H, Xiao B, Zhou H, Zhou F, Shen Z, et al. piR-823, a novel non-coding small RNA, demonstrates in vitro and in vivo tumor suppressive activity in human gastric cancer cells. Cancer Lett 2012;315:12–7. [CrossRef ]
- 3. Iliev R, Fedorko M, Machackova T, Mlcochova H, Svoboda M, Pacik D, et al. Expression Levels of PIWI-interacting RNA, piR-823, are deregulated in tumor tissue, blood serum and urine of patients with renal cell carcinoma. Anticancer Res 2016;36:6419–23. [CrossRef ]
- 4. Yu Y, Xiao J, Hann SS. The emerging roles of PIWI-interacting RNA in human cancers. Cancer Manag Res 2019;11:5895–909.
- 5. Yin J, Jiang XY, Qi W, Ji CG, Xie XL, Zhang DX, et al. piR-823 contributes to colorectal tumorigenesis by enhancing the transcriptional activity of HSF1. Cancer Sci 2017;108:1746–56.
- 6. Li B, Hong J, Hong M, Wang Y, Yu T, Zang S, et al. piRNA-823 delivered by multiple myeloma-derived extracellular vesicles promoted tumorigenesis through re-educating endothelial cells in the tumor environment. Oncogene 2019;38:5227–38.
- 7. Zeng Q, Wan H, Zhao S, Xu H, Tang T, Oware KA, et al. Role of PIWI-interacting RNAs on cell survival: Proliferation, apopto- sis, and cycle. IUBMB Life 2020;72:1870–8. [CrossRef ]
- 8. Peart O. Metastatic breast cancer. Radiol Technol 2017;88:519– 39.
- 9. Foulkes WD, Smith IE, Reis-Filho JS. Triple-negative breast can- cer. N Engl J Med 2010;363:1938–48. [CrossRef ]
- 10. Al-Mahmood S, Sapiezynski J, Garbuzenko OB, Minko T. Meta- static and triple-negative breast cancer: challenges and treat- ment options. Drug Deliv Transl Res 2018;8:1483–507.
- 11. Dent R, Trudeau M, Pritchard KI, Hanna WM, Kahn HK, Sawka CA, et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res 2007;13:4429–34.
- 12. Liedtke C, Mazouni C, Hess KR, André F, Tordai A, Mejia JA, et al. Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. J Clin Oncol 2008;26:1275–81. [CrossRef ]
- 13. Yang X, Phillips DL, Ferguson AT, Nelson WG, Herman JG, Davidson NE. Synergistic activation of functional estrogen receptor (ER)-alpha by DNA methyltransferase and histone deacetylase inhibition in human ER-alpha-negative breast cancer cells. Cancer Res 2001;61:7025–9.
- 14. Rahman M, Pumphrey JG, Lipkowitz S. The TRAIL to targeted therapy of breast cancer. Adv Cancer Res. 2009;103:43–73.
- 15. Zhang Y, Toh L, Lau P, Wang X. Human telomerase reverse tran- scriptase (hTERT) is a novel target of the Wnt/β-catenin path- way in human cancer. J Biol Chem 2012;287:32494–511.
- 16. Leão R, Apolónio JD, Lee D, Figueiredo A, Tabori U, Caste- lo-Branco P. Mechanisms of human telomerase reverse tran- scriptase (hTERT) regulation: clinical impacts in cancer. J Biomed Sci 2018;25:22. [CrossRef ]
- 17. Barthel FP, Wei W, Tang M, Martinez-Ledesma E, Hu X, Amin SB, et al. Systematic analysis of telomere length and somatic alterations in 31 cancer types. Nat Genet 2017;49:349–57.
- 18. Rupaimoole R, Slack FJ. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov 2017;16:203–22. [CrossRef ]
- 19. Mokarram P, Niknam M, Sadeghdoust M, Aligolighasemabadi F, Siri M, Dastghaib S, et al. PIWI interacting RNAs perspectives: a new avenues in future cancer investigations. Bioengineered 2021;12:10401–19. [CrossRef ]
- 20. Asati V, Mahapatra DK, Bharti SK. PI3K/Akt/mTOR and Ras/Raf/ MEK/ERK signaling pathways inhibitors as anticancer agents: Structural and pharmacological perspectives. Eur J Med Chem 2016;109:314–41. [CrossRef ]
- 21. Yan H, Wu QL, Sun CY, Ai LS, Deng J, Zhang L, et al. piRNA-823 contributes to tumorigenesis by regulating de novo DNA methylation and angiogenesis in multiple myeloma. Leuke- mia 2015;29:196–206. [CrossRef ]
- 22. Lord RV, Salonga D, Danenberg KD, Peters JH, DeMeester TR, Park JM, et al. Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adeno- carcinoma sequence. J Gastrointest Surg 2000;4:135–42.
- 23. Bièche I, Noguès C, Paradis V, Olivi M, Bedossa P, Lidereau R, et al. Quantitation of hTERT gene expression in sporadic breast tumors with a real-time reverse transcription-polymerase chain reaction assay. Clin Cancer Res 2000;6:452–9.
- 24. Leu YW, Yan PS, Fan M, Jin VX, Liu JC, Curran EM, et al. Loss of estrogen receptor signaling triggers epigenetic silenc - ing of downstream targets in breast cancer. Cancer Res 2004;64:8184–92. [CrossRef ]
- 25. Calado RT, Yewdell WT, Wilkerson KL, Regal JA, Kajigaya S, Stratakis CA, et al. Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells. Blood 2009;114:2236–43. [CrossRef ]
- 26. Zhao C, Meng L, Hu H, Wang X, Shi F, Wang Y, et al. Sponta- neously immortalised bovine mammary epithelial cells exhib- it a distinct gene expression pattern from the breast cancer cells. BMC Cell Biol 2010;11:82. [CrossRef ]
- 27. Peng L, Song L, Liu C, Lv X, Li X, Jie J, et al. piR-55490 inhibits the growth of lung carcinoma by suppressing mTOR signal- ing. Tumour Biol 2016;37:2749–56. [CrossRef ]
- 28. Ma H, Wang H, Tian F, Zhong Y, Liu Z, Liao A. PIWI-Interacting RNA-004800 Is regulated by S1P receptor signaling pathway to keep myeloma cell survival. Front Oncol 2020;10:438.
- 29. Wu W, Lu BF, Jiang RQ, Chen S. The function and regulation mechanism of piRNAs in human cancers. Histol Histopathol 2021;36:807–16.
- 30. Rizzo F, Rinaldi A, Marchese G, Coviello E, Sellitto A, Cordella A, et al. Specific patterns of PIWI-interacting small noncoding RNA expression in dysplastic liver nodules and hepatocellular carcinoma. Oncotarget 2016;7:54650–61. [CrossRef ]
- 31. Law PT, Qin H, Ching AK, Lai KP, Co NN, He M, et al. Deep sequencing of small RNA transcriptome reveals novel non-coding RNAs in hepatocellular carcinoma. J Hepatol 2013;58:1165–73.
| APA | ÖNER Ç, Colak E (2022). PIWI Interacting RNA-823: Epigenetic Regulator of The Triple Negative Breast Cancer Cells Proliferation. , 339 - 344. 10.14744/ejmo.2022.12505 |
| Chicago | ÖNER Çağrı,Colak Ertugrul PIWI Interacting RNA-823: Epigenetic Regulator of The Triple Negative Breast Cancer Cells Proliferation. (2022): 339 - 344. 10.14744/ejmo.2022.12505 |
| MLA | ÖNER Çağrı,Colak Ertugrul PIWI Interacting RNA-823: Epigenetic Regulator of The Triple Negative Breast Cancer Cells Proliferation. , 2022, ss.339 - 344. 10.14744/ejmo.2022.12505 |
| AMA | ÖNER Ç,Colak E PIWI Interacting RNA-823: Epigenetic Regulator of The Triple Negative Breast Cancer Cells Proliferation. . 2022; 339 - 344. 10.14744/ejmo.2022.12505 |
| Vancouver | ÖNER Ç,Colak E PIWI Interacting RNA-823: Epigenetic Regulator of The Triple Negative Breast Cancer Cells Proliferation. . 2022; 339 - 344. 10.14744/ejmo.2022.12505 |
| IEEE | ÖNER Ç,Colak E "PIWI Interacting RNA-823: Epigenetic Regulator of The Triple Negative Breast Cancer Cells Proliferation." , ss.339 - 344, 2022. 10.14744/ejmo.2022.12505 |
| ISNAD | ÖNER, Çağrı - Colak, Ertugrul. "PIWI Interacting RNA-823: Epigenetic Regulator of The Triple Negative Breast Cancer Cells Proliferation". (2022), 339-344. https://doi.org/10.14744/ejmo.2022.12505 |
| APA | ÖNER Ç, Colak E (2022). PIWI Interacting RNA-823: Epigenetic Regulator of The Triple Negative Breast Cancer Cells Proliferation. Eurasian Journal of Medicine and Oncology, 6(4), 339 - 344. 10.14744/ejmo.2022.12505 |
| Chicago | ÖNER Çağrı,Colak Ertugrul PIWI Interacting RNA-823: Epigenetic Regulator of The Triple Negative Breast Cancer Cells Proliferation. Eurasian Journal of Medicine and Oncology 6, no.4 (2022): 339 - 344. 10.14744/ejmo.2022.12505 |
| MLA | ÖNER Çağrı,Colak Ertugrul PIWI Interacting RNA-823: Epigenetic Regulator of The Triple Negative Breast Cancer Cells Proliferation. Eurasian Journal of Medicine and Oncology, vol.6, no.4, 2022, ss.339 - 344. 10.14744/ejmo.2022.12505 |
| AMA | ÖNER Ç,Colak E PIWI Interacting RNA-823: Epigenetic Regulator of The Triple Negative Breast Cancer Cells Proliferation. Eurasian Journal of Medicine and Oncology. 2022; 6(4): 339 - 344. 10.14744/ejmo.2022.12505 |
| Vancouver | ÖNER Ç,Colak E PIWI Interacting RNA-823: Epigenetic Regulator of The Triple Negative Breast Cancer Cells Proliferation. Eurasian Journal of Medicine and Oncology. 2022; 6(4): 339 - 344. 10.14744/ejmo.2022.12505 |
| IEEE | ÖNER Ç,Colak E "PIWI Interacting RNA-823: Epigenetic Regulator of The Triple Negative Breast Cancer Cells Proliferation." Eurasian Journal of Medicine and Oncology, 6, ss.339 - 344, 2022. 10.14744/ejmo.2022.12505 |
| ISNAD | ÖNER, Çağrı - Colak, Ertugrul. "PIWI Interacting RNA-823: Epigenetic Regulator of The Triple Negative Breast Cancer Cells Proliferation". Eurasian Journal of Medicine and Oncology 6/4 (2022), 339-344. https://doi.org/10.14744/ejmo.2022.12505 |
